Search - tctmd.com

Displaying 141 - 160 of 185

Sort: Relevancy | Date

You Want to Improve Outcomes in DES Patients? The Right Pharmacotherapy Is More Important Than the Right Stent!

Presentation TCT 2013

You Want to Improve Outcomes in DES Patients? The Right Pharmacotherapy Is More Important Than the Right Stent!

Presenter: Gregg Stone

October 28, 2013

Do I Really Need Bioresorbable Scaffolds in the United States?

Presentation TCT 2013

Do I Really Need Bioresorbable Scaffolds in the United States?

Presenter: Gregg Stone

October 28, 2013

Demonstration of Clinical Superiority with a Bioresorbable Vascular Scaffold: The ABSORB IV Clinical Trial

Presentation TCT 2013

Demonstration of Clinical Superiority with a Bioresorbable Vascular Scaffold: The ABSORB IV Clinical Trial

Presenter: Gregg Stone

October 27, 2013

News Daily News

SPIRIT Meta-analysis Confirms Overall Superiority of Xience over Taxus

September 20, 2013

News Daily News

Meta-análisis de SPIRIT confirma superioridad total de Xience sobre Taxus

September 20, 2013

Platelet Reactivity and Clinical Outcomes After Coronary Artery Implantation of DES

Presentation

Platelet Reactivity and Clinical Outcomes After Coronary Artery Implantation of DES

Presenter: Gregg W. Stone

July 30, 2013

News Daily News

HORIZONS-AMI: Bivalirudin, Taxus Improve Outcomes in LAD PCI Patients

July 11, 2013

Drug-Eluting Stents: Past, Present, and Future

Presentation Fellows 2013

Drug-Eluting Stents: Past, Present, and Future

Presenter: Gregg Stone

April 15, 2013

ADAPT-DES One-Year Results: A Large-Scale, Multicenter, Prospective, Observational Study of the Impact of Clopidogrel and Aspirin Hyporesponsiveness on Patient Outcomes

Presentation

ADAPT-DES One-Year Results: A Large-Scale, Multicenter, Prospective, Observational Study of the Impact of Clopidogrel and Aspirin Hyporesponsiveness on Patient Outcomes

Presenter: Gregg W. Stone

March 26, 2013

News Conference News ACC 2013

Is Nobori NEXT? Biodegradable-Polymer DES Noninferior to EES

March 09, 2013

Coronary Calcification in the DES Era: The Forgotten Enemy

Presentation

Coronary Calcification in the DES Era: The Forgotten Enemy

Presenter: Drs. Gary S. Mintz, Philippe Généreux, Mark Reisman, and Gregg W. Stone

February 13, 2013

Two-Year Outcomes Following Implantation of 32mm and 38mm Platinum Chromium Everolimus Eluting Element Stents in Long Coronary Lesions

Presentation TCT 2013

Two-Year Outcomes Following Implantation of 32mm and 38mm Platinum Chromium Everolimus Eluting Element Stents in Long Coronary Lesions

Presenter: Paul Teirstein, Gregg Stone, Ian Meredith, Robert Feldman, Joseph Dens, Abram Rabinowitz, Christophe Dubois, Dominic Allocco, Keith Dawkins

January 31, 2013

$Partial strut fracture in everolimus-eluting stents: An intravascular ultrasound study$

Presentation TCT 2013

Partial strut fracture in everolimus-eluting stents: An intravascular ultrasound study

Presenter: Shinji Inaba, Gary Mintz, Kyeong Yun, Tadayuki Yakushiji, Takehisa Shimizu, Giora Weisz, Martin Leon, Jeffrey Moses, Gregg Stone, Akiko Maehara

January 31, 2013

Impact of Moderate and Severe Coronary Calcification on 1-Year Outcomes after PCI with DES: A Pooled Analysis of 11,651 Patients from 14 Randomized Trials

Presentation TCT 2013

Impact of Moderate and Severe Coronary Calcification on 1-Year Outcomes after PCI with DES: A Pooled Analysis of 11,651 Patients from 14 Randomized Trials

Presenter: Philippe Genereux, Ajay Kirtane, Sorin Brener, Akiko Maehara, Tullio Palmerini, Martin Fahy, Roxana Mehran, Gregg Stone

January 31, 2013

The COAPT Trial: Lessons and Perspectives from the Design Phase

Presentation TCT 2012

The COAPT Trial: Lessons and Perspectives from the Design Phase

Presenter: Gregg Stone

October 25, 2012

ABSORB III and IV (Abbott Vascular) Pivotal Clinical Trial Program

Presentation TCT 2012

ABSORB III and IV (Abbott Vascular) Pivotal Clinical Trial Program

Presenter: Gregg Stone

October 23, 2012

What Definition Should Be Used to Define Periprocedural MI in Clinical Trials and Practice?

Presentation TCT 2012

What Definition Should Be Used to Define Periprocedural MI in Clinical Trials and Practice?

Presenter: Gregg Stone

October 22, 2012

Longitudinal Stent Deformation One Year Later: How Important an Issue Is This?

Presentation TCT 2012

Longitudinal Stent Deformation One Year Later: How Important an Issue Is This?

Presenter: Gregg Stone

October 22, 2012

Everolimus-Eluting Stents: SPIRIT and PLATINUM Update

Presentation TCT 2012

Everolimus-Eluting Stents: SPIRIT and PLATINUM Update

Presenter: Gregg Stone

October 22, 2012

Current and Future DES: Technology and Results

Presentation ACVS 2012

Current and Future DES: Technology and Results

Presenter: Gregg W. Stone

August 03, 2012

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.